drugset / Trial / NCT04914767
Nigella 5 in the Treatment of SARS COV2 (COVID-19)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The world is currently facing a crisis because of this potentially fatal situation of the COVID-19 epidemic without proven efficacy for any drug treatment, while the vaccination is not yet. This epidemic is caused by a new betacorona virus, now called SARS-CoV-2. The most common symptoms reported are fever, cough or chest tightness, and dyspnea. Most cases have a mild course
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-10-30
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NP-101 | Traditional medicine (herbal / TCM) | — | Oral |